{"id":298599,"date":"2026-10-09T13:18:54","date_gmt":"2026-10-09T07:48:54","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=298599"},"modified":"2026-10-09T13:18:54","modified_gmt":"2026-10-09T07:48:54","slug":"neuland-laboratories-share-price-prediction-2027","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/neuland-laboratories-share-price-prediction-2027\/","title":{"rendered":"Neuland Laboratories Share Price Prediction 2027: Scenario Targets, Valuation and Technical Outlook"},"content":{"rendered":"<p style=\"border-left:4px solid #1F4E79;background:#EBF3FB;padding:10px 16px;font-style:italic;\"><em>CMP Rs 20,925.00 (9 Oct 2026). 52W range Rs 11,500.00 to Rs 24,225.00. PE 54.16. 2027 base Rs 25,110, bull Rs 26,156.<\/em><\/p>\n<div style=\"background:#F0F9FF;border-left:4px solid #2E7D32;border-radius:6px;padding:14px 18px;margin:18px 0;\">\n<p style=\"margin:0;color:#1F4E79;font-size:14px;\"><strong>Quick Answer<\/strong><\/p>\n<p style=\"margin:8px 0 0;\">The Neuland Laboratories share price forecast for 2027 centres on a conservative case of Rs 24,064, a base case of Rs 25,110 and a bull case of Rs 26,156, against a current price of Rs 20,925.00. These targets scale today&#8217;s price by reported EPS growth at a constant PE multiple, so they rest on earnings the company has already delivered, not on broker forecasts. The base case implies 20.0% upside from today&#8217;s price. The daily technical setup reads bearish.<\/p>\n<\/p><\/div>\n<p>Neuland Laboratories share price prediction 2027 comes down to earnings growth and the multiple investors pay for it, and the reported numbers give a measured answer. The stock trades at Rs 20,925.00 on NSE as of 9 October 2026, 13.6% below its 52-week high of Rs 24,225.00, after the company reported net profit of Rs 364 crore for FY26.<\/p>\n<p>This Neuland Laboratories stock forecast 2027 builds conservative, base and bull scenarios from exchange-reported financials, shareholding data and daily price indicators, with every assumption shown.<\/p>\n<p style=\"margin-top:24px;\"><a href=\"https:\/\/univest.in\/user\/log-in?utm_source=blogs&#038;utm_medium=share-price-prediction-2027\"><strong>Click Here &#8211; Get Free Investment Predictions<\/strong><\/a><\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/neuland-laboratories-share-price-prediction-2027\/#Neuland_Laboratories_Share_Price_Today_and_Key_Data\" title=\"Neuland Laboratories Share Price Today and Key Data\">Neuland Laboratories Share Price Today and Key Data<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/neuland-laboratories-share-price-prediction-2027\/#What_Is_the_Neuland_Laboratories_Share_Price_Prediction_for_2027\" title=\"What Is the Neuland Laboratories Share Price Prediction for 2027?\">What Is the Neuland Laboratories Share Price Prediction for 2027?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/neuland-laboratories-share-price-prediction-2027\/#Neuland_Laboratories_Share_Price_Forecast_What_Has_to_Go_Right_by_2027\" title=\"Neuland Laboratories Share Price Forecast: What Has to Go Right by 2027\">Neuland Laboratories Share Price Forecast: What Has to Go Right by 2027<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/neuland-laboratories-share-price-prediction-2027\/#Conservative_Case_for_the_Neuland_Laboratories_Share_Price_Target_Rs_24064\" title=\"Conservative Case for the Neuland Laboratories Share Price Target: Rs 24,064\">Conservative Case for the Neuland Laboratories Share Price Target: Rs 24,064<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/neuland-laboratories-share-price-prediction-2027\/#Base_Case_for_the_Neuland_Laboratories_Share_Price_Target_Rs_25110\" title=\"Base Case for the Neuland Laboratories Share Price Target: Rs 25,110\">Base Case for the Neuland Laboratories Share Price Target: Rs 25,110<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/neuland-laboratories-share-price-prediction-2027\/#Bull_Case_for_the_Neuland_Laboratories_Share_Price_Target_Rs_26156\" title=\"Bull Case for the Neuland Laboratories Share Price Target: Rs 26,156\">Bull Case for the Neuland Laboratories Share Price Target: Rs 26,156<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/neuland-laboratories-share-price-prediction-2027\/#Neuland_Laboratories_Financial_Performance_Revenue_Profit_and_Margins\" title=\"Neuland Laboratories Financial Performance: Revenue, Profit and Margins\">Neuland Laboratories Financial Performance: Revenue, Profit and Margins<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/neuland-laboratories-share-price-prediction-2027\/#Is_Neuland_Laboratories_Overvalued_or_Undervalued_Right_Now\" title=\"Is Neuland Laboratories Overvalued or Undervalued Right Now?\">Is Neuland Laboratories Overvalued or Undervalued Right Now?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/neuland-laboratories-share-price-prediction-2027\/#Neuland_Laboratories_Stock_Analysis_Technical_Outlook\" title=\"Neuland Laboratories Stock Analysis: Technical Outlook\">Neuland Laboratories Stock Analysis: Technical Outlook<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/neuland-laboratories-share-price-prediction-2027\/#Neuland_Laboratories_Shareholding_Pattern\" title=\"Neuland Laboratories Shareholding Pattern\">Neuland Laboratories Shareholding Pattern<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/neuland-laboratories-share-price-prediction-2027\/#Key_Risks_to_the_Neuland_Laboratories_Share_Price_Target_for_2027\" title=\"Key Risks to the Neuland Laboratories Share Price Target for 2027\">Key Risks to the Neuland Laboratories Share Price Target for 2027<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/neuland-laboratories-share-price-prediction-2027\/#Earnings_and_Margin_Risk\" title=\"Earnings and Margin Risk\">Earnings and Margin Risk<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/neuland-laboratories-share-price-prediction-2027\/#Valuation_Risk\" title=\"Valuation Risk\">Valuation Risk<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/neuland-laboratories-share-price-prediction-2027\/#Size_and_Liquidity_Risk\" title=\"Size and Liquidity Risk\">Size and Liquidity Risk<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/neuland-laboratories-share-price-prediction-2027\/#Balance_Sheet_Risk\" title=\"Balance Sheet Risk\">Balance Sheet Risk<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/neuland-laboratories-share-price-prediction-2027\/#Technical_Risk\" title=\"Technical Risk\">Technical Risk<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/neuland-laboratories-share-price-prediction-2027\/#Conclusion\" title=\"Conclusion\">Conclusion<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-18\" href=\"https:\/\/univest.in\/blogs-2\/neuland-laboratories-share-price-prediction-2027\/#Frequently_Asked_Questions_on_Neuland_Laboratories_Share_Price_Prediction_2027\" title=\"Frequently Asked Questions on Neuland Laboratories Share Price Prediction 2027\">Frequently Asked Questions on Neuland Laboratories Share Price Prediction 2027<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-19\" href=\"https:\/\/univest.in\/blogs-2\/neuland-laboratories-share-price-prediction-2027\/#What_is_the_Neuland_Laboratories_share_price_target_for_2027\" title=\"What is the Neuland Laboratories share price target for 2027?\">What is the Neuland Laboratories share price target for 2027?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-20\" href=\"https:\/\/univest.in\/blogs-2\/neuland-laboratories-share-price-prediction-2027\/#What_is_the_Neuland_Laboratories_share_price_today\" title=\"What is the Neuland Laboratories share price today?\">What is the Neuland Laboratories share price today?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-21\" href=\"https:\/\/univest.in\/blogs-2\/neuland-laboratories-share-price-prediction-2027\/#Is_Neuland_Laboratories_a_good_stock_to_buy_for_2027\" title=\"Is Neuland Laboratories a good stock to buy for 2027?\">Is Neuland Laboratories a good stock to buy for 2027?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-22\" href=\"https:\/\/univest.in\/blogs-2\/neuland-laboratories-share-price-prediction-2027\/#Can_Neuland_Laboratories_stock_reach_Rs_26156_in_2027\" title=\"Can Neuland Laboratories stock reach Rs 26,156 in 2027?\">Can Neuland Laboratories stock reach Rs 26,156 in 2027?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-23\" href=\"https:\/\/univest.in\/blogs-2\/neuland-laboratories-share-price-prediction-2027\/#What_are_the_support_and_resistance_levels_for_Neuland_Laboratories\" title=\"What are the support and resistance levels for Neuland Laboratories?\">What are the support and resistance levels for Neuland Laboratories?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-24\" href=\"https:\/\/univest.in\/blogs-2\/neuland-laboratories-share-price-prediction-2027\/#What_are_the_main_risks_for_Neuland_Laboratories_stock_in_2027\" title=\"What are the main risks for Neuland Laboratories stock in 2027?\">What are the main risks for Neuland Laboratories stock in 2027?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-25\" href=\"https:\/\/univest.in\/blogs-2\/neuland-laboratories-share-price-prediction-2027\/#How_is_the_Neuland_Laboratories_target_price_for_2027_calculated\" title=\"How is the Neuland Laboratories target price for 2027 calculated?\">How is the Neuland Laboratories target price for 2027 calculated?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Neuland_Laboratories_Share_Price_Today_and_Key_Data\"><\/span><strong>Neuland Laboratories Share Price Today and Key Data<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The Neuland Laboratories share price today is Rs 20,925.00 on NSE, down 0.43% on the day. The market capitalisation stands at Rs 26,961 crore. Over the past year the price has risen 33.1% from Rs 15,717.00. Every Neuland Laboratories stock forecast figure below starts from this price.<\/p>\n<table style=\"border-collapse:collapse;width:100%;margin:16px 0;\">\n<thead>\n<tr>\n<th style=\"border:1px solid #cccccc;padding:8px;text-align:left;background:#F2F2F2;\">Metric<\/th>\n<th style=\"border:1px solid #cccccc;padding:8px;text-align:left;background:#F2F2F2;\">Value<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">Company<\/td>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">Neuland Laboratories (NEULANDLAB)<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">Current Price<\/td>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">Rs 20,925.00<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">52-Week High<\/td>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">Rs 24,225.00 (9 September 2026)<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">52-Week Low<\/td>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">Rs 11,500.00 (23 March 2026)<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">Market Cap<\/td>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">Rs 26,961 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">PE Ratio<\/td>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">54.16<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">Industry PE<\/td>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">37.59<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">PB Ratio<\/td>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">14.39<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">EPS (TTM)<\/td>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">Rs 387.98<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">Return on Equity<\/td>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">19.42%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">Debt to Equity<\/td>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">0.16<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">Dividend Yield<\/td>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">0.16%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">Book Value per Share<\/td>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">Rs 1,460.31<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2><span class=\"ez-toc-section\" id=\"What_Is_the_Neuland_Laboratories_Share_Price_Prediction_for_2027\"><\/span><strong>What Is the Neuland Laboratories Share Price Prediction for 2027?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The Neuland Laboratories share price prediction for 2027 is a conservative case of Rs 24,064, a base case of Rs 25,110 and a bull case of Rs 26,156. Against Rs 20,925.00, these imply 15.0% upside, 20.0% upside and 25.0% upside. They are model scenarios built from reported EPS growth, not broker targets.<\/p>\n<table style=\"border-collapse:collapse;width:100%;margin:16px 0;\">\n<thead>\n<tr>\n<th style=\"border:1px solid #cccccc;padding:8px;text-align:left;background:#F2F2F2;\">Scenario<\/th>\n<th style=\"border:1px solid #cccccc;padding:8px;text-align:left;background:#F2F2F2;\">EPS Growth Basis<\/th>\n<th style=\"border:1px solid #cccccc;padding:8px;text-align:left;background:#F2F2F2;\">EPS Estimate<\/th>\n<th style=\"border:1px solid #cccccc;padding:8px;text-align:left;background:#F2F2F2;\">PE Multiple<\/th>\n<th style=\"border:1px solid #cccccc;padding:8px;text-align:left;background:#F2F2F2;\">Implied Value<\/th>\n<th style=\"border:1px solid #cccccc;padding:8px;text-align:left;background:#F2F2F2;\">Upside vs Current Price<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">Conservative Case<\/td>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">Lower of FY26 growth (39.9%) and 4-year CAGR (54.5%) (capped at 15%)<\/td>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">Rs 446.18 (+15.0%)<\/td>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">Unchanged from today (price to EPS ratio kept constant)<\/td>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">Rs 24,064<\/td>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">+15.0%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">Base Case<\/td>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">Average of the two (capped at 20%)<\/td>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">Rs 465.58 (+20.0%)<\/td>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">Unchanged from today (price to EPS ratio kept constant)<\/td>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">Rs 25,110<\/td>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">+20.0%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">Bull Case<\/td>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">Higher of the two (capped at 25%)<\/td>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">Rs 484.98 (+25.0%)<\/td>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">Unchanged from today (price to EPS ratio kept constant)<\/td>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">Rs 26,156<\/td>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">+25.0%<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Each target takes today&#8217;s price of Rs 20,925.00 and scales it by the EPS growth assumed for that case, which is the same as holding the PE multiple constant. The conservative case uses the lower of the FY26 EPS growth and the 4-year EPS CAGR, the base case uses their average and the bull case uses the higher figure. Together they form the Neuland Laboratories target price range for the FY27 outlook over the next 12 months, and the range is not a point estimate.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Neuland_Laboratories_Share_Price_Forecast_What_Has_to_Go_Right_by_2027\"><\/span><strong>Neuland Laboratories Share Price Forecast: What Has to Go Right by 2027<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Each Neuland Laboratories target price below depends on a specific EPS outcome, and the text states that outcome next to the number.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Conservative_Case_for_the_Neuland_Laboratories_Share_Price_Target_Rs_24064\"><\/span><strong>Conservative Case for the Neuland Laboratories Share Price Target: Rs 24,064<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Reaching Rs 24,064 needs EPS to rise 15.0% to Rs 446.18 while the stock keeps its current PE multiple. That follows the slower 4-year EPS CAGR of 54.5%.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Base_Case_for_the_Neuland_Laboratories_Share_Price_Target_Rs_25110\"><\/span><strong>Base Case for the Neuland Laboratories Share Price Target: Rs 25,110<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Reaching Rs 25,110 needs EPS to rise 20.0% to Rs 465.58, the average of the FY26 growth rate and the 4-year CAGR. Net profit growth of 962.4% in Q1 FY27 is at or above that pace, which supports the target.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Bull_Case_for_the_Neuland_Laboratories_Share_Price_Target_Rs_26156\"><\/span><strong>Bull Case for the Neuland Laboratories Share Price Target: Rs 26,156<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Reaching Rs 26,156 needs EPS to rise 25.0% to Rs 484.98 with the PE multiple held at today&#8217;s level. That is above the 52-week high of Rs 24,225.00, so it would need a fresh breakout. A daily close above the nearest resistance level of Rs 22,324.08 (50-day SMA) would be the first technical confirmation.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Neuland_Laboratories_Financial_Performance_Revenue_Profit_and_Margins\"><\/span><strong>Neuland Laboratories Financial Performance: Revenue, Profit and Margins<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Neuland Laboratories earned net profit of Rs 364 crore on revenue of Rs 2,053.15 crore in FY26, with profit up 39.9% and revenue up 37.1% compared with FY25. Diluted EPS was Rs 283.71 against Rs 202.74 a year earlier, and that earnings base anchors the Neuland Laboratories share price forecast.<\/p>\n<table style=\"border-collapse:collapse;width:100%;margin:16px 0;\">\n<thead>\n<tr>\n<th style=\"border:1px solid #cccccc;padding:8px;text-align:left;background:#F2F2F2;\">Year<\/th>\n<th style=\"border:1px solid #cccccc;padding:8px;text-align:left;background:#F2F2F2;\">Revenue (Rs Cr)<\/th>\n<th style=\"border:1px solid #cccccc;padding:8px;text-align:left;background:#F2F2F2;\">Net Profit (Rs Cr)<\/th>\n<th style=\"border:1px solid #cccccc;padding:8px;text-align:left;background:#F2F2F2;\">EPS (Rs)<\/th>\n<th style=\"border:1px solid #cccccc;padding:8px;text-align:left;background:#F2F2F2;\">Operating Margin<\/th>\n<th style=\"border:1px solid #cccccc;padding:8px;text-align:left;background:#F2F2F2;\">Net Margin<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">FY22<\/td>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">953.15<\/td>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">63.82<\/td>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">49.74<\/td>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">15.21%<\/td>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">6.70%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">FY23<\/td>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">1,200.95<\/td>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">163.52<\/td>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">127.45<\/td>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">23.64%<\/td>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">13.62%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">FY24<\/td>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">1,571.12<\/td>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">300.08<\/td>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">233.89<\/td>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">30.49%<\/td>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">19.10%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">FY25<\/td>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">1,497.35<\/td>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">260.11<\/td>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">202.74<\/td>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">23.77%<\/td>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">17.37%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">FY26<\/td>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">2,053.15<\/td>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">364.00<\/td>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">283.71<\/td>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">29.89%<\/td>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">17.73%<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>In the latest reported quarter, Q1 FY27 (quarter ended June 2026), revenue was Rs 650.07 crore against Rs 300.61 crore a year earlier (+116.3%), and the bottom line was a net profit of Rs 147.67 crore against a net profit of Rs 13.90 crore (+962.4%). Operating margin was 36.06% versus 14.46% in the year-ago quarter. Cash flow from operations was Rs 346.68 crore in FY26 against Rs 317.40 crore in FY25. Together these figures set the earnings base for the Neuland Laboratories share price prediction.<\/p>\n<p style=\"margin-top:24px;\"><a href=\"https:\/\/univest.in\/screeners\"><strong>Check the Univest Screener for live Neuland Laboratories fundamentals<\/strong><\/a><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Is_Neuland_Laboratories_Overvalued_or_Undervalued_Right_Now\"><\/span><strong>Is Neuland Laboratories Overvalued or Undervalued Right Now?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Neuland Laboratories trades at a PE of 54.16 against an industry PE of 37.59, which places the stock at a 44.1% premium to the industry average. The price-to-book ratio is 14.39 on a book value of Rs 1,460.31 per share. Return on equity of 19.42% means the company earns Rs 19.42 of profit for every Rs 100 of shareholder equity.<\/p>\n<p>Debt to equity is 0.16, so borrowings equal about 16% of shareholder equity. The company declared a dividend of Rs 34.00 per share for FY26, a yield of 0.16% at the current price. This valuation context frames the Neuland Laboratories stock price prediction for 2027 without relying on any outside forecast.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Neuland_Laboratories_Stock_Analysis_Technical_Outlook\"><\/span><strong>Neuland Laboratories Stock Analysis: Technical Outlook<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Neuland Laboratories stock trades below its 50-day SMA of Rs 22,324.08 and above its 200-day EMA of Rs 18,370.05, and the combined daily indicators read bearish. The 52-week high of Rs 24,225.00 was set on 9 September 2026, while the 52-week low of Rs 11,500.00 came on 23 March 2026.<\/p>\n<table style=\"border-collapse:collapse;width:100%;margin:16px 0;\">\n<thead>\n<tr>\n<th style=\"border:1px solid #cccccc;padding:8px;text-align:left;background:#F2F2F2;\">Indicator<\/th>\n<th style=\"border:1px solid #cccccc;padding:8px;text-align:left;background:#F2F2F2;\">Reading<\/th>\n<th style=\"border:1px solid #cccccc;padding:8px;text-align:left;background:#F2F2F2;\">Signal<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">RSI (14)<\/td>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">18.38<\/td>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">Oversold<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">MACD (12,26,9)<\/td>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">-334.63 vs signal -188.85<\/td>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">Bearish<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">ADX (14)<\/td>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">54.24<\/td>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">Established trend<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">Supertrend (10,3)<\/td>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">Price below Rs 23,198.00<\/td>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">Bearish<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">50-day SMA<\/td>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">Rs 22,324.08<\/td>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">Price below<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">200-day EMA<\/td>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">Rs 18,370.05<\/td>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">Price above<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>The nearest support level sits at Rs 18,370.05 (200-day EMA) and Rs 11,500.00 (52-week low). The nearest resistance level sits at Rs 22,324.08 (50-day SMA) and Rs 23,198.00 (Supertrend). A sustained move above the nearest resistance would support the Neuland Laboratories share price prediction 2027 base case, and this Neuland Laboratories stock analysis uses daily candles only. Chart signals add context to the Neuland Laboratories share price target without changing the earnings maths.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Neuland_Laboratories_Shareholding_Pattern\"><\/span><strong>Neuland Laboratories Shareholding Pattern<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Promoters hold 32.62% of Neuland Laboratories as of Jun 2026, down from 32.68% in Jun 2025 across the last 5 quarters. FII holding is 21.08% (down from 21.69% in Jun 2025) and DII holding is 16.51% (up from 11.57% in Jun 2025), which puts combined institutional holding at 37.59%. Public shareholders own 29.79%. Shareholding data is one input for any Neuland Laboratories stock forecast.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Key_Risks_to_the_Neuland_Laboratories_Share_Price_Target_for_2027\"><\/span><strong>Key Risks to the Neuland Laboratories Share Price Target for 2027<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Earnings_and_Margin_Risk\"><\/span><strong>Earnings and Margin Risk<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Operating margin has ranged from 15.21% to 30.49% between FY22 and FY26, so a slip toward the lower end would trim the EPS estimate behind the Neuland Laboratories stock forecast. Revenue was up 37.1% in FY26, and slower revenue growth would weigh on the profit path.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Valuation_Risk\"><\/span><strong>Valuation Risk<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The PE of 54.16 is 44.1% above the industry PE of 37.59. Every target here holds the multiple constant, so a narrowing of that premium would leave returns below these targets even if earnings grow as assumed.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Size_and_Liquidity_Risk\"><\/span><strong>Size and Liquidity Risk<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Market capitalisation stands at Rs 26,961 crore. Investors should check daily traded volumes and order book depth on NSE before sizing a position, because price moves can be sharper when volumes thin out. Liquidity is a practical constraint on any Neuland Laboratories stock price target.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Balance_Sheet_Risk\"><\/span><strong>Balance Sheet Risk<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Debt to equity of 0.16 means borrowings stand at about 16% of shareholder equity. A rise in borrowing costs or a jump in debt would weigh on profit and on the multiple behind the Neuland Laboratories share price forecast.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Technical_Risk\"><\/span><strong>Technical Risk<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The daily indicators read bearish, so the targets above may need a technical turn before the price follows earnings. A daily close below Rs 18,370.05 (200-day EMA) would weaken the setup further.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Conclusion\"><\/span><strong>Conclusion<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>This Neuland Laboratories stock analysis puts the share price target range for 2027 at Rs 24,064 to Rs 26,156, with a base case of Rs 25,110 against Rs 20,925.00 today. The inputs are a PE of 54.16 that sits at a 44.1% premium to the industry average, EPS growth of 39.9% in FY26 and a daily technical setup that reads bearish. The next quarterly result will show which scenario is gaining ground. This analysis is educational, so consult a SEBI-registered advisor before acting on it.<\/p>\n<p style=\"margin-top:24px;\"><em>Download the <a href=\"https:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\">Univest iOS App<\/a> or <a href=\"https:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&#038;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\">Univest Android App<\/a> to track Neuland Laboratories live price and get daily stock recommendations.<\/em><\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/p><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions_on_Neuland_Laboratories_Share_Price_Prediction_2027\"><\/span><strong>Frequently Asked Questions on Neuland Laboratories Share Price Prediction 2027<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_Neuland_Laboratories_share_price_target_for_2027\"><\/span><strong>What is the Neuland Laboratories share price target for 2027?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The Neuland Laboratories share price forecast for 2027 has a conservative case of Rs 24,064, a base case of Rs 25,110 and a bull case of Rs 26,156. These are model scenarios based on reported EPS growth, and they are not guaranteed outcomes.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_Neuland_Laboratories_share_price_today\"><\/span><strong>What is the Neuland Laboratories share price today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Neuland Laboratories trades at Rs 20,925.00 on NSE as of 9 October 2026, down 0.43% on the day. The 52-week range is Rs 11,500.00 to Rs 24,225.00.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_Neuland_Laboratories_a_good_stock_to_buy_for_2027\"><\/span><strong>Is Neuland Laboratories a good stock to buy for 2027?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The data points in different directions: the PE of 54.16 is at a 44.1% premium to the industry average, EPS grew 39.9% in FY26 and the daily technical setup reads bearish. This article does not constitute investment advice, so consult a SEBI-registered advisor before deciding.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Can_Neuland_Laboratories_stock_reach_Rs_26156_in_2027\"><\/span><strong>Can Neuland Laboratories stock reach Rs 26,156 in 2027?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Reaching Rs 26,156 needs EPS to rise 25.0% from Rs 387.98 with the PE multiple held at today&#8217;s level, plus a daily close above Rs 22,324.08 (50-day SMA). This is a scenario, not a guarantee.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_are_the_support_and_resistance_levels_for_Neuland_Laboratories\"><\/span><strong>What are the support and resistance levels for Neuland Laboratories?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The nearest support levels are Rs 18,370.05 (200-day EMA) and Rs 11,500.00 (52-week low), and the nearest resistance levels are Rs 22,324.08 (50-day SMA) and Rs 23,198.00 (Supertrend).<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_are_the_main_risks_for_Neuland_Laboratories_stock_in_2027\"><\/span><strong>What are the main risks for Neuland Laboratories stock in 2027?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The main risks to the Neuland Laboratories share price forecast are a fall in operating margin from the 15.21% to 30.49% range seen since FY22, slower revenue growth after FY26 revenue was up 37.1%, and thin trading volumes. Debt to equity of 0.16 adds balance sheet sensitivity.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_is_the_Neuland_Laboratories_target_price_for_2027_calculated\"><\/span><strong>How is the Neuland Laboratories target price for 2027 calculated?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Each target scales the current price by assumed EPS growth at a constant PE multiple. The conservative case uses 15.0% growth, the base case 20.0% and the bull case 25.0%, all drawn from the company&#8217;s reported FY26 and 4-year EPS growth.<\/p>\n<p><script type=\"application\/ld+json\">{\"@context\":\"https:\/\/schema.org\",\"@type\":\"FAQPage\",\"mainEntity\":[{\"@type\":\"Question\",\"name\":\"What is the Neuland Laboratories share price target for 2027?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The Neuland Laboratories share price forecast for 2027 has a conservative case of Rs 24,064, a base case of Rs 25,110 and a bull case of Rs 26,156. These are model scenarios based on reported EPS growth, and they are not guaranteed outcomes.\"}},{\"@type\":\"Question\",\"name\":\"What is the Neuland Laboratories share price today?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Neuland Laboratories trades at Rs 20,925.00 on NSE as of 9 October 2026, down 0.43% on the day. The 52-week range is Rs 11,500.00 to Rs 24,225.00.\"}},{\"@type\":\"Question\",\"name\":\"Is Neuland Laboratories a good stock to buy for 2027?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The data points in different directions: the PE of 54.16 is at a 44.1% premium to the industry average, EPS grew 39.9% in FY26 and the daily technical setup reads bearish. This article does not constitute investment advice, so consult a SEBI-registered advisor before deciding.\"}},{\"@type\":\"Question\",\"name\":\"Can Neuland Laboratories stock reach Rs 26,156 in 2027?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Reaching Rs 26,156 needs EPS to rise 25.0% from Rs 387.98 with the PE multiple held at today's level, plus a daily close above Rs 22,324.08 (50-day SMA). This is a scenario, not a guarantee.\"}},{\"@type\":\"Question\",\"name\":\"What are the support and resistance levels for Neuland Laboratories?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The nearest support levels are Rs 18,370.05 (200-day EMA) and Rs 11,500.00 (52-week low), and the nearest resistance levels are Rs 22,324.08 (50-day SMA) and Rs 23,198.00 (Supertrend).\"}},{\"@type\":\"Question\",\"name\":\"What are the main risks for Neuland Laboratories stock in 2027?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The main risks to the Neuland Laboratories share price forecast are a fall in operating margin from the 15.21% to 30.49% range seen since FY22, slower revenue growth after FY26 revenue was up 37.1%, and thin trading volumes. Debt to equity of 0.16 adds balance sheet sensitivity.\"}},{\"@type\":\"Question\",\"name\":\"How is the Neuland Laboratories target price for 2027 calculated?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Each target scales the current price by assumed EPS growth at a constant PE multiple. The conservative case uses 15.0% growth, the base case 20.0% and the bull case 25.0%, all drawn from the company's reported FY26 and 4-year EPS growth.\"}}]}<\/script><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Neuland Laboratories share price prediction 2027: base case Rs 25,110, bull case Rs 26,156 and a conservative case of Rs 24,064, built from reported EPS growth, valuation, technical levels and shareholding data.<\/p>\n","protected":false},"author":29,"featured_media":298598,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[24],"tags":[1007,1019],"class_list":["post-298599","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-market","tag-pharma-stocks","tag-stock-market"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["298598"],"rank_math_title":["Neuland Laboratories Share Price Prediction 2027"],"rank_math_description":["Neuland Laboratories share price prediction 2027: conservative Rs 24,064, base Rs 25,110, bull Rs 26,156. Valuation, financials, technical levels and risks explained."],"rank_math_focus_keyword":["Neuland Laboratories share price prediction 2027 | Density Target: 1.2-1.5%"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/10\/neuland-laboratories-share-price-prediction-2027-scenario-targets-valuation-and.webp","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/298599","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/29"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=298599"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/298599\/revisions"}],"predecessor-version":[{"id":298600,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/298599\/revisions\/298600"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/298598"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=298599"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=298599"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=298599"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}